Application 213107
- Type
- ANDA
- Sponsor
- SUN PHARM INDS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PALBOCICLIB | PALBOCICLIB | CAPSULE; ORAL | 75MG | No | No |
| 002 | PALBOCICLIB | PALBOCICLIB | CAPSULE; ORAL | 100MG | No | No |
| 003 | PALBOCICLIB | PALBOCICLIB | CAPSULE; ORAL | 125MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibrance | PALBOCICLIB | U.S. Pharmaceuticals | 89a142d5-7e61-48bf-9e77-e2cd124c4792 | 2026-07-06 | Warnings, Adverse reactions | PALBOCICLIB |
| Ibrance | PALBOCICLIB | Pfizer Laboratories Div Pfizer Inc | fecbdd7d-b729-41b5-9872-231b8fe104ce | 2026-07-02 | Warnings, Adverse reactions | PALBOCICLIB |
| Ibrance | PALBOCICLIB | Pfizer Laboratories Div Pfizer Inc | e0e6412f-50b4-4fd4-9364-62818d121a07 | 2026-07-02 | Warnings, Adverse reactions | PALBOCICLIB |